Trial to explore more effective treatments for seriously ill COVID-19 patients A major trial is underway to explore how artificial intelligence can be used to develop more effective treatments for very ill COVID-19 patients. Dr Brijesh Patel, Clinical Senior Lecturer at Imperial College London and Honorary Consultant at Royal Brompton & Harefield NHS Foundation Trust, is leading a trial to test a new AI device to […]
July 14, 2020 A quarter of COVID-19 patients enrolled in major Imperial study More than 66,000 patients with COVID-19 have so far been enrolled in a UK-wide study to learn more about the disease, says an Imperial researcher. Professor Peter Openshaw, from Imperial College London’s National Heart and Lung Institute, who is an Honorary Physician at Imperial College Healthcare NHS Trust, is one of three researchers leading Europe’s […]
July 9, 2020 Researchers explain antibody testing work to track COVID-19 infections in the UK Experts at Imperial have outlined their work to develop effective antibody tests to monitor the spread of COVID-19 infections in a new video. Researchers at Imperial College London are working with clinicians at Imperial College Healthcare NHS Trust on a programme of work to develop a ‘gold standard’ antibody test to support the Trust’s testing […]
July 2, 2020 Convalescent blood plasma given to COVID-19 patients An Imperial researcher discussed a trial giving UK COVID-19 patients blood plasma from people who have recovered from coronavirus, in a recent talk. Professor Anthony Gordon, Chair in Anaesthesia and Critical Care at Imperial College London and a Consultant in Intensive Care Medicine at Imperial College Healthcare NHS Trust, is leading a trial to investigate […]
COVID-19 vaccine technology can be used for future pandemics, says expert The researcher developing a potential new coronavirus vaccine said the technology behind it could also be used for future pandemics, in a recent talk. Professor Robin Shattock, from the Department of Infectious Diseases at Imperial College London, is leading the development of a candidate vaccine. It is currently being tested in human trials to establish […]